Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers {4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy}acetic acid  (CAS No.: 475085-57-5) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.

Application: An orally available and long-acting prostacyclin receptor agonist prodrug. Used for the treatment of pulmonary arterial hypertension. An active metabolite of Selexipag.

Find More Selexipag/UPTRAVI Intermediates>>>